Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Clin Cancer Res. 2013 Mar 20;19(9):2442–2450. doi: 10.1158/1078-0432.CCR-12-3283

Table 2.

Spearman rank correlation of clinicopathologic variables with PCA3 and TMPRSS2:ERG scores.

Variable N rs p-value
Serum PSA PCA3 score 387 0.09 0.07
T2:ERG score 387 0.03 0.5
Age PCA3 score 387 0.25 < 0.0001
T2:ERG score 387 0.04 0.47
Prostate volume PCA3 score 302 0.007 0.9
T2:ERG score 302 0.03 0.56
Body mass index PCA3 score 387 −0.03 0.61
T2:ERG score 387 −0.08 0.13
Number of prior biopsies PCA3 score 387 0.07 0.16
T2:ERG score 387 0.09 0.08
Time from biopsy to urine collection PCA3 score 387 0.009 0.9
T2:ERG score 387 0.05 0.3
Time from diagnosis to urine collection PCA3 score 387 0.09 0.07
T2:ERG score 387 0.07 0.17
Gleason score at study entry PCA3 score 387 0.13 0.01
T2:ERG score 387 0.2 0.0001
Tumor volume at study entry (% positive cores) PCA3 score 294 0.18 0.002
T2:ERG score 294 0.3 <0.001